it has been confirmed that substantial vascularization is an effective strategy to heal large-scale bone defects in the field of bone tissue engineering. the local application of deferoxamine (dfo) is among the most common and effective methods for promoting the formation of blood vessels, although its short half-life in plasma, rapid clearance, and poor biocompatibility limit its therapeutic suitability. herein, zeolitic imidazolate framework-8 (zif-8) was selected as a vehicle to extend the half-life of dfo. in the present study, a nano dfo-loaded zif-8 (dfo@zif-8) drug delivery system was established to promote angiogenesis–osteogenesis coupling. the nanoparticles were characterized, and their drug loading efficiency was examined to confirm the successful synthesis of nano dfo@zif-8. additionally, due to the sustained release of dfo and zn2 , dfo@zif-8 nps were able to promote angiogenesis in human umbilical vein endothelial cells (huvecs) culture and osteogenesis in bone marrow stem cells (bmscs) in vitro. furthermore, the dfo@zif-8 nps promoted vascularization by enhancing the expression of type h vessels and a vascular network. the dfo@zif-8 nps promoted bone regeneration in vivo by increasing the expression of ocn and bmp-2. rna sequencing analysis revealed that the pi3k-akt-mmp-2/9 and hif-1α pathways were upregulated by dfo@zif-8 nps in huvecs, ultimately leading to the formation of new blood vessels. in addition, the mechanism by which dfo@zif-8 nps promoted bone regeneration was potentially related to the synergistic effect of angiogenesis–osteogenesis coupling and zn2 -mediation of the mapk pathway. taken together, dfo@zif-8 nps, which were demonstrated to have low cytotoxicity and excellent coupling of angiogenesis and osteogenesis, represent a promising strategy for the reconstruction of critical-sized bone defects.
